PolyPeptide Group

PolyPeptide Group is a Manufacturer/Innovator company operating in the pharmaceutical industry.

PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India.

Company type

Manufacturer/Innovator

Products and services

Custom Manufacturing, APIs (Active Pharmaceutical Ingredients)

Markets

Oceania, North America (USA, Canada), Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)

Useful Links

Connect with PolyPeptide Group on LinkedIn

Address

PolyPeptide Group, P.O. Box 30089 , Limhamn, Sweden, Sweden, SE-200 61